Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02620748Phase 1Completed
Phase 1, randomised, double-blind trial of tranexamic acid in uterine leiomyoma (2 arms), sponsored by George Washington University. Primary endpoint: Intraoperative Estimated Blood Loss. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02620748.